Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal Cancer
Clinical trial NCT00305734 · COMPLETED
Trial details
- NCT number
- NCT00305734
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2007-07-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.